Back to Search

EMILY CORCORAN, M.D.

M.D.

Family Medicine Physician

NPI: 1952720575IndividualAccepts Medicare

Specialties, Licenses & Credentials

Family Medicine PhysicianPrimary

Family Medicine

Code: 207Q00000X

DR.0056816(CO)2020029415(MO)

CMS Specialties

PrimaryFAMILY PRACTICE

Education

UNIVERSITY OF MISSOURI, COLUMBIA SCHOOL OF MEDICINE

Class of 2014

Research & Publications (16)

Tumor necrosis factor-alpha and interleukin-1 antagonists alleviate inflammatory skin changes associated with epidermal growth factor receptor antibody therapy in mice.
PMID 19584274·Cancer Res·2009
7-preclinical
Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer models.
PMID 19528458·Anticancer Res·2009
7-preclinical
In vivo method for establishing synergy between antibodies to epidermal growth factor receptor and vascular endothelial growth factor receptor-2.
PMID 19252838·Methods Mol Biol·2009
7-preclinical
Pharmacodynamics of RWJ-54428 against Staphylococcus aureus, Streptococcus pneumoniae, and Enterococcus faecalis in a neutropenic mouse thigh infection model.
PMID 17954697·Antimicrob Agents Chemother·2008
7-preclinical
Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
PMID 17085673·Clin Cancer Res·2006
7-preclinical
Pharmacodynamics of levofloxacin against Pseudomonas aeruginosa with reduced susceptibility due to different efflux pumps: do elevated MICs always predict reduced in vivo efficacy?
PMID 16641428·Antimicrob Agents Chemother·2006
7-preclinical
Synergistic antitumor effects of combined epidermal growth factor receptor and vascular endothelial growth factor receptor-2 targeted therapy.
PMID 16609035·Clin Cancer Res·2006
4-observational
1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors.
PMID 16246560·Bioorg Med Chem Lett·2006
7-preclinical
Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic target.
PMID 15767546·Mol Cancer Ther·2005
7-preclinical
A fully human recombinant IgG-like bispecific antibody to both the epidermal growth factor receptor and the insulin-like growth factor receptor for enhanced antitumor activity.
PMID 15757893·J Biol Chem·2005
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
7900 LEES SUMMIT RD
KANSAS CITY, MO 64139

Quick Facts

NPI
1952720575
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
12
Publications
16

Are you this provider?

Claim Your Profile